Skip to content

Effect of Sodium Alendronate on the Final Implant Stability.

Effect of Sodium Alendronate Versus Sticky Bone as Socket Preservation Materials on the Final Implant Stability. A Randomized Clinical Trial

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05162885
Enrollment
24
Registered
2021-12-17
Start date
2021-05-01
Completion date
2022-10-01
Last updated
2021-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Labial Wall Defect

Keywords

Stability, Sodium Alendronate, Implant, Sticky bone

Brief summary

evaluation of the final implant stability after its placement in sockets preserved with two different socket preservation materials

Detailed description

compare the stability of implant placement using Osstell ISQ resonance frequency analyzer, and marginal bone resorption and bone density around implant by X-ray analysis in different socket preservation techniques comparing sodium alendronate with the sticky bone graft technique

Interventions

PROCEDURESocket Preservation technique

Implant placement after Socket preservation Technique with sodium alderonate versus sticky bone in salama&salama Class 3 labial wall defect

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients with seeking implant drive prosthesis after socket has been preserved by either technique. * Patients with seeking implant drive prosthesis with Salama Class 3 defective sockets. * Both genders males and females will be included.

Exclusion criteria

* General contraindications to implant surgery. * Patient seeking immediate implant placement. * Subjected to irradiation in the head and neck area less than 1 year before implantation. * Untreated periodontitis. * Poor oral hygiene and motivation. * Uncontrolled diabetes. * Pregnant or nursing. * Substance abuse. * Psychiatric problems or unrealistic expectations. * Severe bruxism or clenching. * Immunosuppressed or immunocompromised. * Treated or under treatment with intravenous amino-bisphosphonates. * Active infection or severe inflammation in the area intended for implant placement. * Unable to open mouth sufficiently to accommodate the surgical tooling. * Patients participating in other studies, if the present protocol could not be properly * followed. Referred only for implant placement or unable to attend a 5-year follow-up

Design outcomes

Primary

MeasureTime frameDescription
Implant stability3-4 months after Dental implant placementCalculate the final implant stability of two groups using Osstell resonance frequency analyzer

Secondary

MeasureTime frameDescription
marginal bone3-4 months after Dental implant placementEvaluation of marginal bone resorption around implant in two groups using superimposition x-ray (CBCT) software analysis

Other

MeasureTime frameDescription
Bone Density3-4 months after Dental implant placementEvaluation of bone density around the placed implants using x-ray (CBCT) software analysis

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026